| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
|
Dai M.-S.; Liu L.-C.; Wang M.-Y.; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO; Huang C.-S.; Yeh D.-C.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Lin P.-H. |
| 臺大學術典藏 |
2022-07-29T03:18:01Z |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
|
Lin P.-H.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Yeh D.-C.; Dai M.-S.; Liu L.-C.; MING-YANG WANG; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-03-10T06:14:59Z |
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens
|
Dai M.S.; Feng Y.H.; Chen S.W.; Masuda N.; Yau T.; Chen S.T.; YEN-SHEN LU; Yap Y.S.; Ang P.C.S.; Chu S.C.; Kwong A.; Lee K.S.; Ow S.; Kim S.B.; Lin J.; Chung H.C.; Ngan R.; Kok V.C.; Rau K.M.; Sangai T.; Ng T.Y.; Tseng L.M.; Bryce R.; Bebchuk J.; Chen M.C.; Hou M.F. |
| 臺大學術典藏 |
2022-03-10T02:31:35Z |
Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells
|
Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN; Dai M.-S.; Tseng L.-M. |
| 臺大學術典藏 |
2021-06-03T06:15:35Z |
Varlitinib downregulates HER/ERK signaling and induces apoptosis in triple negative breast cancer cells
|
Liu C.-Y.;Chu P.-Y.;Huang C.-T.;Chen J.-L.;Yang H.-P.;Wang W.-L.;Lau K.-Y.;Lee C.-H.;Lan T.-Y.;Huang T.-T.;Po-Han Lin;Dai M.-S.;Tseng L.-M.; Liu C.-Y.; Chu P.-Y.; Huang C.-T.; Chen J.-L.; Yang H.-P.; Wang W.-L.; Lau K.-Y.; Lee C.-H.; Lan T.-Y.; Huang T.-T.; PO-HAN LIN; Dai M.-S.; Tseng L.-M. |
| 臺大學術典藏 |
2021-03-10T02:36:31Z |
Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ? 2 HER2-directed regimens: Phase III NALA trial
|
Saura C.; Oliveira M.; Feng Y.-H.; Dai M.-S.; Chen S.-W.; Hurvitz S.A.; Kim S.-B.; Moy B.; Delaloge S.; Gradishar W.; Masuda N.; Palacova M.; Trudeau M.E.; Mattson J.; Yap Y.S.; Hou M.-F.; De Laurentiis M.; Yeh Y.-M.; Chang H.-T.; Yau T.; Wildiers H.; Haley B.; Fagnani D.; YEN-SHEN LU; Crown J.; Lin J.; Takahashi M.; Takano T.; Yamaguchi M.; Fujii T.; Yao B.; Bebchuk J.; Keyvanjah K.; Bryce R.; Brufsky A.; NALA Investigators |
| 國立成功大學 |
2021 |
High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis
|
Lien, M.-Y.;Yeh, S.-P.;Gau, J.-P.;Wang, P.-N.;Li, S.-S.;Dai, M.-S.;Chen, T.C.;Hsieh, P.-Y.;Chiou, L.-W.;Huang, W.-H.;Liu, Y.-C.;Ko, B.-S.;(TBMTR), Taiwan Blood and Marrow Transplantation Registry |
| 臺大學術典藏 |
2020-05-25T06:51:44Z |
Oral paclitaxel and HM30181A demonstrate clinical activity in metastatic breast cancer (MBC) patients
|
Dai M.-S;Chao T.-Y;Chao T.-C;Chiu C.-F;Yen-Shen Lu;Shiah H.-S;Wu Y.-Y;Gerald Fetterly G;Hung N;Cutler D.L;Kwan R;Douglas Kramer D;Chan W.-K;Hung T.; Dai M.-S; Chao T.-Y; Chao T.-C; Chiu C.-F; YEN-SHEN LU; Shiah H.-S; Wu Y.-Y; Gerald Fetterly G; Hung N; Cutler D.L; Kwan R; Douglas Kramer D; Chan W.-K; Hung T. |
| 國立成功大學 |
2020 |
Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Phase III NALA trial
|
Saura, C.;Oliveira, M.;Feng, Y.-H.;Dai, M.-S.;Chen, S.-W.;Hurvitz, S.A.;Kim, S.-B.;Moy, B.;Delaloge, S.;Gradishar, W.;Masuda, N.;Palacova, M.;Trudeau, M.E.;Mattson, J.;Yap, Yap Y.S.;Hou, M.-F.;De, Laurentiis M.;Yeh, Yeh Y.-M.;Chang, H.-T.;Yau, T.;Wildiers, H.;Haley, B.;Fagnani, D.;Lu, Y.-S.;Crown, J.;Lin, J.;Takahashi, M.;Takano, Takano T.;Yamaguchi, M.;Fujii, T.;Yao, B.;Bebchuk, J.;Keyvanjah, Keyvanjah K.;Bryce, R.;Brufsky, A.;Investigators, NALA |
| 臺大學術典藏 |
2015 |
Amiodarone Induces Overexpression of Similar to Versican b to Repress the EGFR/ Gsk3b/Snail Signaling Axis during Cardiac Valve Formation of Zebrafish Embryos
|
CHIA-TI TSAI; Tsai H.-J.; Lee H.-C.; Lo H.-C.; Lo D.-M.; Su M.-Y.; Hu J.-R.; Wu C.-C.; Chang S.-N.; Dai M.-S. |
| 國立臺灣科技大學 |
2011 |
Effects of nano-scale living core-shell rubber on the volume shrinkage in the cure of vinyl ester and epoxy resins
|
Huang, Y.J.;Chen, S.L.;Dai, M.S.;Oktavia, H.;Lin, J.C. |
